Abinet Aklilu
Yale University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Abinet Aklilu as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 03:55 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT07273838 · Sodium-Glucose Cotransporter-2 Inhibitor for Patients With Acute Cardiorenal SyndromeYale University · recruiting · Heart Failure, Acute Kidney Injury · principal investigator
- Ph2NCT06111768 · Sodium-Glucose Cotransporter-2 Inhibitor for Acute Cardiorenal Syndrome: A Feasibility StudyYale University · completed · Cardiorenal Syndrome · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 03:55 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Sodium Glucose Cotransporter-2 Inhibitors for the Amelioration of Acute Cardio-Renal SyndromeK23DK142042 · NIDDK · YALE UNIVERSITY · fiscal years 2025 to 2026 · $192,258 awarded in 2026Grant number is on one of their registry trials
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 03:55 UTC. The ranking covers the 200 most relevant of 2 PubMed records, and a shared surname and initials can bring in a namesake. All 2 on PubMed